MissionIR Articles
Original content written and distributed as part of our ongoing relationships.
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Announces Positive Results in Ongoing Phase 2 Combination Therapy Trial with MS1819
AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company, recently announced positive results from the first five patients in its Phase 2 combination therapy trial of MS1819 for the treatment of severe exocrine pancreatic insufficiency (“EPI”) in…
-
MissionIRNewsBreaks – Predictive Oncology (NASDAQ: POAI) CEO Provides Company Updates on Exclusive NNW Audio Interview
Predictive Oncology (NASDAQ: POAI) CEO Carl Schwartz was featured in a recent NetworkNewsWire (“NNW”) audio interview. During the interview, Schwartz provided updates on the company’s subsidiaries, noted recent company milestones and outlined near-term goals. POAI,…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) to Announce Q3 2020 Results, Host Conference Call
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, will release financial results for the third quarter ended September 30, 2020, after market close on Monday, October 26, 2020. According to the…
-
MissionIRNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Appoints Eric Chapdelaine to Senior Manufacturing Team
Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for cancer and diabetes patients, today announced the promotion of Eric Chapdelaine to vice president of manufacturing. According to the update, Chapdelaine’s promotion…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Featured in Seeking Alpha Article Discussing Its Disruption in Chronic Disease Market
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, was featured in a recent Seeking Alpha news article. The piece, titled “DarioHealth: Don’t Overlook This Mini Livongo,” discusses disruptors in the chronic disease market,…
-
SPAC Merger Fires Boosters for 180 Life Sciences’ Exploration in Unmet Medical Needs of Anti-inflammatories Space
Biotechnology company 180 Life Sciences has launched a variety of advanced clinical and preclinical-stage efforts to develop novel anti-inflammatory treatments for patients with chronic illnesses A planned merger with 180 Life Sciences advanced under a…
-
CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Moves Closer to IND Filing as Manufacturing of Lead Drug Candidate Commences
Berubicin Expected to Commence Trials for the Treatment of Glioblastoma, An Aggressive Form of Brain Cancer Currently Considered Incurable Production of Berubicin Begins in the U.S. and Europe Dual Manufacturing Facilities Engaged to Reduce Supply…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Forms New Partnership with KOA(R) and Yogi Bear’s Jellystone Park(TM) Camp-Resorts
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that it is now an approved vendor for Kampgrounds of America (“KOA”(R))…
-
Cybin Corp. Appoints New CEO with Impressive Health-Care Expertise
Cybin appoints health-care expert Doug Drysdale as new CEO. Company confident that his extensive health-care sector background, international company management skills will strengthen Cybin partnerships. New CEO says business model, talented management team positions company…
-
MissionIRNewsBreaks – Net Element Inc. (NASDAQ: NETE), Mullen Technologies Ramping Up for EV Production
Net Element (NASDAQ: NETE) is transforming its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. Mullen Technologies recently announced commencement of the build out of…
-
MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Digital Spotlight on Telehealth Services, Smart Technology
Trxade Group NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, was showcased at several recent virtual conferences and events. In a realm not limited by location, the company’s leadership took advantage of the opportunity…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Partners with Northwestern University to Develop DED Additive Processes
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process, quality-assurance software for the commercial 3D-printing industry, has announced a new partnership with Northwestern University designed to develop its PrintRite3D(TM) In-Process Quality Assurance technology across an…
-
MissionIRNewsBreaks – 180 Life Sciences Corp. Featured in NNW Editorial Discussing Big Pharma Acquisitions
180 Life Sciences Corp. was discussed prominently in an editorial published by NetworkNewsWire (“NNW”), one of 50-plus brands in the InvestorBrandNetwork (“IBN”). The editorial, titled “Banking on the Next Blockbuster Drug,” discusses the significant amounts of time…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Forms New Scientific Advisory Board
AzurRx BioPharma (NASDAQ: AZRX), a clinical-stage biopharmaceutical company focused on developing treatments for gastrointestinal diseases using recombinant proteins, has announced the formation of a Scientific Advisory Board (“SAB”) designed to provide the company with invaluable expertise…
-
Predictive Oncology Inc. (NASDAQ: POAI) Industry Leader in Growing Precision Medicine Market
Recent study reports CAGR of 9.7% in precision medicine space. Predictive Oncology focused on use of data, artificial intelligence to develop personalized cancer therapies. One of POAI’s primary projects is building multi-omic predictive models of…
-
MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces Completion of Manufacturing of Lead Drug Candidate
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the central nervous system, has completed the manufacturing process for Berubicin Drug Product. CNSP’s U.S.…
-
MissionIRNewsBreaks – Why CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Is ‘One to Watch’
CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system. A recent article discussing CNS Pharmaceuticals reads, “The…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Deploys ‘Augmented Reality Immersive Classes’ to China-Based Kindergartens
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into agreements with six kindergartens…
-
MissionIRNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) BIGtoken Expands Board to Form ‘Powerhouse’ Leadership Team
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, together with BIGtoken(R) Inc., a company started as a division of SRAX, today announced the addition of Daina Middleton and Yin Woon Rani to its board of…
-
SRAX Inc. (NASDAQ: SRAX) Spinoff BIGtoken(R) Inc. Announces George Stella as Chief Revenue Officer
George Stella appointed chief revenue officer of BIGtoken following executive vice president tenure at SRAX SRAX moving BIGtoken to separate publicly traded company through definitive share exchange agreement with Force Protection Video Equipment Corp BIGtoken…
-
MissionIRNewsBreaks – Net Element Inc.’s (NASDAQ: NETE) Foray into EV Market Driven by Dragonfly K50
Net Element (NASDAQ: NETE) has recently transformed its business model to become a pure-play electric vehicle (“EV”) manufacturer through its merger with privately-held Mullen Technologies Inc. The company is set to begin marketing its initial…
-
180 Life Sciences Corp. Expands IP Portfolio with EU, U.S., and Chinese Patents
The company’s patent portfolio includes its own intellectual property and exclusive worldwide licenses, including in the U.S., Canada, Europe, Australia, Hong Kong, and China 180 Life Sciences is in the final stages of its merger…
-
MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) Path to Commercialization Targets Multibillion Hemp-Derived CBD Market
Pressure BioSciences (OTCQB: PBIO), a developer of innovative solutions for the worldwide life science and other industries, recently achieved another milestone as it nears initial production of commercial systems expected to revolutionize the nanoemulsification process…
-
MissionIRNewsBreaks – Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Looks to Bright Future with First Contract on the Books
Predictive Oncology (NASDAQ: POAI)’s Soluble Biotech division has finalized its first substantial contract with a pharmaceutical company since its acquisition by POAI earlier this year (https://ibn.fm/gXjd2). Soluble Biotech is a provider of stable and soluble…
-
Net Element Inc. (NASDAQ: NETE) Well-Poised to Capitalize as EV Market Set to Grow by 29% per Annum Over Next Decade
Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020 Mullen expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 followed by its own…
-
AzurRx BioPharma Inc. (NASDAQ: AZRX) is “One to Watch”
AzurRx BioPharma’s lead therapeutic, MS1819, is a recombinant lipase treatment for exocrine pancreatic insufficiency and is currently targeting patients with cystic fibrosis and chronic pancreatitis – an established global market of more than $2 billion…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Announces Date, Time for Q3 2020 Results Conference Call
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process, quality-assurance software for the commercial 3D-printing industry, has scheduled a conference call to discuss its third-quarter 2020 results. The call is scheduled for Thursday, Oct. 22,…
-
MissionIRNewsBreaks – Sustainable Green Team Ltd. (SGTM) Secures Contract with City of Vero Beach, Florida
Sustainable Green Team (OTC: SGTM), a leading provider of environmentally beneficial solutions for tree and storm waste disposal, today announced that its wholly owned subsidiary, Mulch Manufacturing Inc., was awarded a one-year natural mulch supply…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Host Q3 2020 Live Video Conference Webcast
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced that it will hold a live Zoom video webcast to discuss its financial and operational results for the third quarter ended September 30,…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expands Flagship Brand to Fill the Void in Club Market, Specialty Retailers
The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that its new 2-liter six-pack packaging for its flagship brand, Alkaline88(R), will…
-
180 Life Sciences Corp. Bringing Hope to Those Afflicted by Dupuytren’s Disease and Other Inflammatory Conditions
180 Life Sciences is a clinical-stage biotechnology company developing anti-tumor necrosis factor (“TNF”) therapies to treat a variety of inflammatory conditions. Phase 2b/3 clinical trials on fibrosis and inflammation-causing TNF irregularity are currently underway with…
-
MissionIRNewsBreaks – Wrap Technologies Inc. (NASDAQ: WRTC) to Sponsor 2020 Protecting New York Summit Virtual Event
Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, has announced that it will sponsor this week’s 2020 Protecting New York Summit. The virtual event, scheduled for Thursday, Oct. 15, 2020, provides an opportunity…
-
MissionIRNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Landmark Acquisition Featured in Stock2Me Podcast
SRAX (NASDAQ: SRAX), an innovative fintech solutions provider, was featured in the latest episode of The Stock2Me Podcast, an InvestorBrandNetwork (“IBN”) solution to provide specialized content distribution via widespread syndication channels. The episode features Christopher…
-
MissionIRNewsBreaks – AzurRx BioPharma Inc. (NASDAQ: AZRX) Adds More Sites for Cystic Fibrosis Clinical Trials
AzurRx BioPharma (NASDAQ: AZRX) has activated additional clinical trial sites for its trial of MS1819 in cystic fibrosis. The company specializes in the development of nonsystemic, recombinant therapies for gastrointestinal diseases. The company has activated two additional trial…
-
MissionIRNewsBreaks – Sigma Labs Inc. (NASDAQ: SGLB) Enters Strategic Alliance to Build ‘Smart Factories of the Future’
Sigma Labs (NASDAQ: SGLB), a leading developer of in-process quality assurance software for the commercial 3D metal printing industry, today announced its partnership with IN4.OS, a leader in advanced manufacturing. Under the collaboration, the partners…
-
MissionIRNewsBreaks – Trxade Group Inc.’s (NASDAQ: MEDS) Bonum Health Partners with SingleCare to Enhance Enterprise Telehealth Solutions
Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and health-care platform, today announced that its Bonum Health subsidiary has partnered with SingleCare, the prescription savings service. According to the update, the collaboration is designed…
-
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Takes Another Step Closer to Q1 Launch of Brain Cancer Drug Trial
CNS Pharmaceuticals is a pre-clinical-stage developer of novel brain cancer-fighting drugs, including its lead candidate Berubicin The company is working to build on promising results from a 2006 Phase I trial, which provided 44 percent…
-
Predictive Oncology Inc. (NASDAQ: POAI) CEO Schwartz Pens Letter to Shareholders, Elaborates on Ongoing Company Developments
Predictive Oncology’s CEO Carl Schwartz published open letter to company’s shareholders Schwartz elaborated on various developments within each of POAI’s divisions, has reiterated his optimism on company’s operations going forward CEO also revealed that company’s…
-
MissionIRNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Serial Entrepreneur as New Chief Operating Officer
Processa Pharmaceuticals (NASDAQ: PCSA), a clinical-stage biopharmaceutical company developing products to improve survival and/or quality of life for patients who have high unmet medical needs, has appointed a new chief operating officer. Michael Floyd, a…
-
MissionIRNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Platform Selected for Integration in Vitality’s Gateway Flex
DarioHealth (NASDAQ: DRIO), a pioneer in the global digital-therapeutics market, today announced that Vitality Group has chosen the company’s digital therapeutics solutions for inclusion in Vitality’s new Gateway Flex offering. According to the update, Gateway…
Search Articles
Latest Articles
- BluSky AI Inc. (BSAI): Democratizing AI Through Modular Infrastructure and a New Neocloud That Scales from Startup to Enterprise
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund
- Brera Holdings PLC (NASDAQ: BREA) Gains Outperform Rating from PartnerCap Securities, Price Target Set at $11.50
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch